The Multi-Billion-Dollar Battle For Metsera's Obesity Drugs
In this week's edition of InnovationRx, we look at the battle for Metsera, the departure of FDA's top drug regulator, Kimberly-Clark's $40 billion Kenvue deal, and more.
(Forbes, 2025-11-05T18:00:16Z)